Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Observational
data indicate that low-density lipoprotein cholesterol (LDL-C) levels are strongly positively …

AIM: To build a consensus among Chilean specialists on the appropriate management of
patients with nonalcoholic fatty liver disease (NAFLD) in clinical practice. METHODS …

The impact of NPC1L1 and ezetimibe on cholesterol absorption are well documented.
However, their potential consequences relative to absorption and metabolism of other …

Lowering of low-density lipoprotein cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitors (statins) is clearly efficacious in the treatment and prevention of …

Aims The predominance of small dense low-density lipoproteins (sdLDLs) has been
associated with increased cardiovascular risk. The effect of ezetimibe on LDL subfraction …

Auricularia delicate (ADe), an edible fungus belonging to the family Auriculariaceae and
order Auriculariales, possesses antimicrobial, hepatoprotective, and antioxidant effects. In …

Lowering serum cholesterol levels reduces the risk of coronary heart disease (CHD)-related
events. Statins are commonly prescribed as first-line treatment but many patients at high-risk …

The primary aim of lipid-related cardiovascular disease (CVD) risk management is the
lowering of LDL-C levels. Numerous studies have shown that statins, which inhibit …

Evidence of the effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
(statins) within continuum of atherothrombotic conditions and particularly in the treatment …

Introduction: In the light of the most recent and stricter dyslipidemia treatment guidelines, the
need for combination hypolipidemic therapy is increasing. Ezetimibe plus simvastatin is …